Modified MBS-MCP RNA Tagging System for mRNA Dynamics

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The existing MS2-MCP system for visualizing mRNA in yeast cells is impaired by MCP binding, leading to spurious results due to inhibition of cytoplasmic exonuclease activity and accumulation of 3' decay fragments, which complicates the visualization of mRNA degradation dynamics.

Innovation Solution

A new MBS-MCP system is designed with reduced affinity between the MS2 loops and MCP, featuring longer linkers and shorter stem-loops, allowing for accurate visualization of mRNA from transcription to degradation by minimizing the formation of aggregates and ensuring full-length mRNA detection.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If the MS2-MCP system is used to visualize mRNA in yeast cells, then mRNA detection is achieved, but cytoplasmic exonuclease activity is inhibited leading to accumulation of 3' decay fragments

Engineering Contradiction:
ImprovemRNA detection accuracyVSAvoidinhibition of cytoplasmic exonuclease activity
Core Design Contradiction:
Measurement precisionVSObject-generated harmful factors

Solution Approach 1:

The patent introduces a modified MS2 loop sequence that acts as an intermediary with reduced affinity for MCP, allowing the system to detect mRNA without strongly inhibiting exonuclease activity. The modified loop serves as a mediator that maintains detection capability while reducing harmful interactions with degradation machinery.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the biochemical parameters of the MS2 loop by modifying its nucleotide sequence to reduce binding affinity for MCP. This parameter change allows the system to function at a binding strength that permits exonuclease access while maintaining sufficient signal for detection.

Inventive Principle:
Principle #35Parameter changes

2Measurement precision

If multiple MS2 loops are used to enhance signal, then mRNA visualization sensitivity increases, but formation of MBS aggregates increases

Engineering Contradiction:
ImprovemRNA visualization sensitivityVSAvoidformation of MBS aggregates
Core Design Contradiction:
Measurement precisionVSStability of the object's composition

Solution Approach 1:

The patent modifies the loop sequence parameters to reduce MCP binding affinity, which prevents the formation of stable aggregates even when multiple loops are present. This parameter change allows multiple loops to be used for enhanced sensitivity without the harmful aggregation effect.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The modified MS2 loops are designed to be transient and non-aggregating, serving as disposable detection elements that can be used in multiple copies without forming stable complexes. This allows high sensitivity through multiple copies while avoiding the stability issue of aggregates.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Ease of operation

If the existing MBS-MCP system is used, then mRNA localization can be studied, but spurious results are obtained due to degradation inhibition

Engineering Contradiction:
ImprovemRNA localization study capabilityVSAvoidaccuracy of degradation dynamics data
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent changes the binding affinity parameter of the MS2-MCP interaction by modifying the loop sequence. This creates a system that is sufficiently stable for localization studies but sufficiently labile to allow natural degradation processes, thereby improving reliability of degradation dynamics data.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent uses a modified system that provides partial binding affinity - enough to allow localization studies but not excessive binding that would inhibit degradation. This partial action approach maintains ease of operation for localization while improving reliability for degradation studies.

Inventive Principle:
Principle #16Partial or excessive action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The new system effectively reduces the accumulation of MBS aggregates, enabling precise visualization and monitoring of mRNA dynamics, including degradation, without interfering with the cytoplasmic exonuclease activity, thus providing accurate kinetic data on mRNA life cycle events.

Implementation Method 1

the MS2 binding sites (MBS) and the MS2 coat protein homo-dimer (MCP) interact to control viral particle assembly

Methodology Applied
Scientific EffectProtein-RNA binding:

Implementation Method 2

co-expression of MCP fused with fluorescent proteins renders single mRNAs visible using wide-field epi-fluorescence microscopy

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentUS20240110231A1RNA tagging system for visualization of single mRNA molecules
Publication Date: 2024.04.04 ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIV
  • US20240110231A1 patent drawing
  • US20240110231A1 patent drawing
  • US20240110231A1 patent drawing

AI summary

An RNA tagging system for visualization of single mRNA molecules based on a MSB-MCP system, as well as methods of use.